Description
NURECA LIMITED has fixed December 12, 2025 as the record date to determine shareholders eligible to participate in the buyback offer.
Summary
NURECA LIMITED (Scrip Code: 543264) has announced a buyback of equity shares through a tender offer. The company has set December 12, 2025 as the record date to determine the eligibility and names of shareholders who can participate in the buyback offer. Shares will trade on an ex-entitlement basis from December 12, 2025 under settlement number DR-776/2025-2026.
Key Points
- Company: NURECA LIMITED (Scrip Code: 543264)
- Record Date: December 12, 2025
- Ex-Entitlement Date: December 12, 2025
- Settlement Number: DR-776/2025-2026
- Purpose: Determine eligible shareholders for buyback participation
- Security Type: Dematerialised securities in rolling settlement segment
Regulatory Changes
No regulatory changes introduced. This is a standard corporate action notification.
Compliance Requirements
- Trading members must take note of the record date and ex-entitlement date
- Only shareholders holding shares as of the record date (December 12, 2025) will be eligible to participate in the buyback
- Shares purchased on or after the ex-entitlement date will not carry buyback eligibility
Important Dates
- Notice Date: December 10, 2025
- Record Date: December 12, 2025
- Ex-Entitlement Date: December 12, 2025
- Settlement Number: DR-776/2025-2026
Impact Assessment
Impact on Shareholders: Medium impact for NURECA shareholders. Those holding shares as of the record date can tender their shares in the buyback offer, potentially providing an exit opportunity at the buyback price.
Market Impact: Limited broader market impact. The ex-entitlement trading from December 12, 2025 may result in price adjustment as shares trade without buyback rights.
Liquidity Impact: Temporary reduction in floating stock if the buyback is successful, potentially affecting liquidity in NURECA shares post-buyback completion.
Impact Justification
Medium importance as it affects only NURECA shareholders who wish to participate in the buyback. Limited market-wide impact but significant for company investors.